[#item_full_content] Prospective observational study reports improvements in pain-related outcomes, mental health measures, and quality of life among patients using physician-authorized medical cannabis in the Canadian Journal of PainTORONTO, Jan. 30, 2026 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, today announced the pub Read More
PSN Briefings
Plain-English cannabis industry updates — what changed, what didn’t, and why it matters.
Episode 1 • Federal Rescheduling — What Actually ChangedLatest PSN Briefs
Short, plain-English updates from the PSN desk
- What federal rescheduling did NOT change
- Why state cannabis boards still control outcomes
- What operators should not assume in 2026